Open AccessOne-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia
Author(s) -
Petros Drosos,
Kolbjørn Brønnick,
Inge Joa,
Jan Olav Johannessen,
Erik Johnsen,
Rune A. Kroken,
Helen J. Stain,
Wenche ten Velden Hegelstad,
Tor Ketil Larsen
Publication year - 2020
Publication title -
journal of clinical psychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.786
H-Index - 121
eISSN - 1533-712X
pISSN - 0271-0749
DOI - 10.1097/jcp.0000000000001303
Subject(s) - clozapine , schizophrenia (object oriented programming) , antipsychotic , medicine , psychiatry , psychosis , pediatrics
Remission in schizophrenia is difficult to achieve. Antipsychotic drugs are critical in the treatment of schizophrenia. International guidelines for the pharmacological treatment of schizophrenia recommend a 3-step algorithm with clozapine being the third-line antipsychotic agent. This study investigated the 1-year outcome and the application of the guidelines for the pharmacological treatment of nonremitted first-episode schizophrenia (FES) patients during the first year of follow-up.